AIM
GHDX

Assured Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Assured Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,012
Closed -$841K – 1086
2019
Q1 		$841K Sell
12,012
-11,176
-48% -$829K 0.01% 424
2018
Q4 		$1.49M Buy
23,188
+2,102
+10% +$147K 0.04% 388
2018
Q3 		$1.48M Sell
21,086
-13,046
-38% -$763K 0.03% 480
2018
Q2 		$1.72M Sell
34,132
-13,226
-28% -$525K 0.03% 431
2018
Q1 		$1.48M Buy
+47,358
New +$1.57M 0.03% 422

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Assured Investment Management's GHDX Position: Q2 2019 in Review

Assured Investment Management sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 12,012 shares — an estimated $841K sold.

Assured Investment Management first reported a position in GHDX in Q1 2018 and held it in 5 quarters. The position peaked at $1.72M in Q2 2018. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • Assured Investment Management reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 12,012 Genomic Health, Inc. shares in Q2 2019, an estimated $841K.
  • Assured Investment Management first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Genomic Health, Inc. position peaked at $1.72M in Q2 2018.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.